Results 21 to 30 of about 163,866 (279)

Therapeutic efficacy and safety of ACE inhibitors in the hypertensive paediatric population: a review [PDF]

, 2016
Purpose: Since 1997, strong incentives have been introduced worldwide to improve access to safe and effective medicines addressing the therapeutic needs of children. ACE inhibitors, the most prescribed antihypertensive drugs in the paediatric population,
De Bruyne, Pauline, Snauwaert, Evelien, Vande Walle, Johan   +2 more
core   +3 more sources

ACE inhibitors [PDF]

British Journal of Clinical Pharmacology, 2002
Edited by P. D’Orlèans‐Juste & G. E. Plante
 Published by Birkhauser [Milestones in drug therapy series]
 187 pages, price @116, ISBN 3‐7643‐5982 ...
N. F. Kelland, D. J. Webb
openaire   +1 more source

Unrecognized recurrent perioperative angioedema requiring intubation in a patient taking long-term angiotensin-converting enzyme inhibitor therapy

Otolaryngology Case Reports, 2022
Introduction: Angiotensin converting enzyme (ACE) inhibitors are a leading class of antihypertensives, which are a well-documented cause of angioedema related to prescription drugs. The purpose of this report is to highlight the importance of recognition
Christopher Wojcik, Brian Farrell
doaj   +1 more source

The use of angiotensin-converting enzyme inhibitors in general medicine

South African Family Practice, 2012
Angiotensin-converting enzyme (ACE) inhibitors are a class of drugs commonly used in the management of hypertension, congestive heart failure, cerebrovascular disease, stable coronary heart disease and diabetes-associated nephropathy.
M.L.I. Mashitisho
doaj   +1 more source

The toxicity of angiotensin converting enzyme inhibitors to larvae of the disease vectors Aedes aegypti and Anopheles gambiae [PDF]

, 2017
The control of mosquitoes is threatened by the appearance of insecticide resistance and therefore new control chemicals are urgently required. Here we show that inhibitors of mosquito peptidyl dipeptidase, a peptidase related to mammalian angiotensin ...
A Enayati, A Vandingenen, A Vandingenen, ACM Camargo, AD Haddow, C Harrison, CM Rylett, CS Anthony, D Borovsky, D Borovsky, D Borovsky, DW Cushman, DW Cushman, E Lemeire, EG Erdos, EK Thomsen, G Wijffels, H Ranson, HR Corradi, HR Corradi, JJ Xu, K Arnold, K Hens, KR Acharya, L Bordoli, L Vercruysse, M Akif, M Akif, M Biasini, MA Hayashi, MA Johansson, MA Ondetti, MJ Cornell, N Basso, N Macours, NS Lamango, NS Lamango, NS Lamango, P Corvol, R Natesh, R Natesh, RE Isaac, RE Isaac, RJ Siviter, RL Soffer, S Burnham, S Kumar, S McNicholas, SH Ferreira, TA Williams, U Ekbote, U Ekbote, UV Ekbote, VR Chintapalli, X Houard   +54 more
core   +4 more sources

Prodrug ACE Inhibitors [PDF]

Circulation, 1998
To the Editor: In a recent issue of Circulation , Brown and Vaughan1 reviewed ACE inhibitors. They stated that captopril and lisinopril are active drugs and listed 7 other ACE inhibitors approved in the United States that are inactive prodrugs until metabolized in the liver.
openaire   +2 more sources

Angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers on insulin sensitivity in hypertensive patients: A meta-analysis of randomized controlled trials.

PLoS ONE, 2021
IntroductionThis meta-analysis aimed to summarize the available evidence to compare angiotensin-converting enzyme (ACE) inhibitors with angiotensin II receptor blockers (ARBs) on improving insulin sensitivity in hypertensive patients.MethodsRandomized ...
Jia Yao, Simin Fan, Xiaoyan Shi, Xiayu Gong, Jia Zhao, Guanjie Fan   +5 more
doaj   +1 more source

Suppression of experimental abdominal aortic aneurysms in the rat by treatment with angiotensin-converting enzyme inhibitors [PDF]

, 2001
Purpose: Pathologic remodeling of the extracellular matrix is a critical mechanism in the development and progression of abdominal aortic aneurysms (AAAs).
Liao, Shixiong, Miralles, Manuel, Kelley, Brian J., Curci, John A., Borhani, Martin, Thompson, Robert W.   +5 more
core   +1 more source

ACE INHIBITOR POSSIBILITIES IN CLINICAL PRACTICE: WHAT WE KNOW ABOUT THEM?

Рациональная фармакотерапия в кардиологии, 2016
New possibilities of ACE inhibitors application on the base of international trails review are presented. Traditional therapy areas of ACE inhibitors (hypertension, heart failure) are well known.
D. V. Nebieridze, A. S. Safarian
doaj   +1 more source

Angiotensin-I-Converting Enzyme and its Relatives [PDF]

, 2011
Angiotensin-I-converting enzyme (ACE) is a monomeric, membrane-bound, zinc- and chloridedependent peptidyl dipeptidase that catalyzes the conversion of the decapeptide angiotensin I to the octapeptide angiotensin II, by removing a carboxy-terminal ...
Riordan, James Francis
core   +1 more source